Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?

Kotaro Miyao, Hirofumi Yokota, R. Leo Sakemura

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?'. Together they form a unique fingerprint.

Medicine & Life Sciences